MB Therapeutika Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo data| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2023 |
|---|
| 0 |
| - |
| 0 |
| 0 |
| - |
| - |
| - |
| 0 |
| 220 |
| 0 |
| 220 |
| 2024 |
|---|
| 193,083 |
| 26,522 |
| 28,323 |
| 26,449 |
| 3,633 |
| 57.29 |
| 13.70 |
| 26,449 |
| 24,555 |
| 0 |
| 51,041 |
| 2025 |
|---|
| 272,648 |
| 44,550 |
| 27,006 |
| 24,290 |
| 3,969 |
| 57.79 |
| 8.91 |
| 34,740 |
| 39,389 |
| 37,490 |
| 35,640 |
Register and
explore Okredo data| 2025 |
|---|
| 272,648 |
| 44,550 |
| 27,006 |
| 24,290 |
| 3,969 |
| 57.79 |
| 8.91 |
| 34,740 |
| 39,389 |
| 37,490 |
| 35,640 |
Register and
explore Okredo dataTurnover (€)
2025
Turnover (€)
272,648 €41 % *
Sales per employee (€)
44,550 €68 % *
Profit before tax (€)
27,006 €-5 % *
Net Profit (€)
24,290 €-8 % *
Profit per employee (€)
3,969 €9 % *
Total profitability (%)
57.79 %0.87 % *
Net profitability (%)
8.91 %-34.96 % *
Equity (€)
34,740 €31 % *
Amounts Payable And Liabilities (€)
39,389 €60 % *
Non-current Assets (€)
37,490 €- *
CurrentAssets (€)
35,640 €-30 % *
